122 related articles for article (PubMed ID: 19321845)
1. Botulinum toxin for neuropathic pain?
Apfel SC
Neurology; 2009 Apr; 72(17):1456-7. PubMed ID: 19321845
[No Abstract] [Full Text] [Related]
2. Using botulinum toxin to treat diabetic foot pain.
Kaufman JL; Karceski S
Neurology; 2009 Apr; 72(17):e82-5. PubMed ID: 19398700
[No Abstract] [Full Text] [Related]
3. Botulinum toxins for analgesia.
Smith HS
Pain Physician; 2009; 12(3):479-81. PubMed ID: 19461815
[No Abstract] [Full Text] [Related]
4. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial: botulinum toxin for neuropathic pain?
Torgovnick J; Arsura E; Sethi NK; Hu CJ; Yuan RY; Sheu JJ; Apfel SC
Neurology; 2010 Jan; 74(1):92; author reply 92-3. PubMed ID: 20038781
[No Abstract] [Full Text] [Related]
6. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
7. Sensory profiles: A new strategy for selecting patients in treatment trials for neuropathic pain.
Cruccu G; Truini A
Pain; 2009 Nov; 146(1-2):5-6. PubMed ID: 19625126
[No Abstract] [Full Text] [Related]
8. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Piovesan EJ; Teive HG; Kowacs PA; Della Coletta MV; Werneck LC; Silberstein SD
Neurology; 2005 Oct; 65(8):1306-8. PubMed ID: 16247065
[TBL] [Abstract][Full Text] [Related]
9. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Zakrzewska JM; Cohen J; Brown J; Alksne J; Gemillion H; Linskey M; Sirois D; Pollock B
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685762
[No Abstract] [Full Text] [Related]
10. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Brenner SR
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16682696
[No Abstract] [Full Text] [Related]
11. [Pilot study with pyrimidine nucleotides. Less pain in diabetic polyneuropathy].
Müller D
MMW Fortschr Med; 2002 Nov; 144(46):61. PubMed ID: 12534085
[No Abstract] [Full Text] [Related]
12. Chili peppers, nerve regeneration, and clinical trial design.
Herrmann DN; Bromberg MB
Neurology; 2007 Apr; 68(16):1247-8. PubMed ID: 17438212
[No Abstract] [Full Text] [Related]
13. Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy.
Guastella V; Mick G
Diabetes Metab; 2009 Feb; 35(1):12-9. PubMed ID: 19046917
[TBL] [Abstract][Full Text] [Related]
14. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Voller B; Sycha T; Gustorff B; Kranz G; Auff E
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685761
[No Abstract] [Full Text] [Related]
15. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction.
Kitamura Y; Matsuka Y; Spigelman I; Ishihara Y; Yamamoto Y; Sonoyama W; Kamioka H; Yamashiro T; Kuboki T; Oguma K
Neuroscience; 2009 Apr; 159(4):1422-9. PubMed ID: 19409226
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide for the treatment of diabetic neuropathic pain.
Biton V
Expert Rev Neurother; 2008 Nov; 8(11):1649-60. PubMed ID: 18986235
[TBL] [Abstract][Full Text] [Related]
17. [Long-term safety of therapeutic botulinum toxin A].
Naumann M
Nervenarzt; 2008 Jun; 79 Suppl 1():41-3. PubMed ID: 18927966
[TBL] [Abstract][Full Text] [Related]
18. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.
Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD
Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901
[TBL] [Abstract][Full Text] [Related]
19. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy.
Rivard PF; Nugent AC; Symons FJ
Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
